2018Scandinavian Journal of Infectious DiseasesRequires access

Frequency of cross-resistance to rilpivirine and etravirine among HIV-1 subtype C infected individuals failing nevirapine/efavirenz based ART regimen

Veena Vadhini Ramalingam, John Paul Demosthenes, Ben C Ghale, Priscilla Rupali, George M. Varghese, O C Abraham, Rajesh Kannangai

Open publisher page 2 citations

Abstract

Sir,In a recent review of the present journal on antiretroviral treatment for HIV infection, the choice of non-nucleoside reverse transcriptase inhibitor (NNRTi) was discussed [1]. Based on availab...

About this research paper

What this paper is about

Sir,In a recent review of the present journal on antiretroviral treatment for HIV infection, the choice of non-nucleoside reverse transcriptase inhibitor (NNRTi) was discussed [1]. Based on availab...

Why it matters

OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Sir,In a recent review of the present journal on antiretroviral treatment for HIV infection, the choice of non-nucleoside reverse transcriptase inhibitor (NNRTi) was discussed [1]. Based on availab...

Key concepts: Nevirapine, Rilpivirine, Etravirine, Efavirenz, Medicine, Regimen, Virology, Human immunodeficiency virus (HIV)

Related papers

Back to paper searchBrowse research topicsOriginal source
Frequency of cross-resistance to rilpivirine and etravirine among HIV-1 subtype C infected individuals failing nevirapine/efavirenz based ART regimen — Research Paper | ScholarLens